Esposito Pamela is Chief Business Officer of Replimune Group Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kymera Therapeutics, Inc.
20 Jun 24
144
Replimune Group, Inc.
23 May 24
4
Replimune Group, Inc.
13 Sep 23
4
Replimune Group, Inc.
24 Aug 23
4
Replimune Group, Inc.
15 Aug 23
4
Replimune Group, Inc.
11 Jul 23
144
Replimune Group, Inc.
10 Jul 23
4
Kymera Therapeutics, Inc.
20 Jun 23
4
Replimune Group, Inc.
18 May 23
4
Replimune Group, Inc.
4 Apr 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jun 24 | KYMR Kymera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 31.2 | 16,000 | 499.20 k | 16,000 |
12 Sep 23 | REPL Replimune | Common Stock | Sell | Dispose S | No | Yes | 20 | 300 | 6.00 k | 263,436 |
12 Sep 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 3.3 | 300 | 990.00 | 263,736 |
12 Sep 23 | REPL Replimune | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.3 | 300 | 990.00 | 86,033 |
11 Sep 23 | REPL Replimune | Common Stock | Sell | Dispose S | No | Yes | 20.01 | 5,358 | 107.21 k | 263,436 |
11 Sep 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 3.3 | 5,358 | 17.68 k | 268,794 |
11 Sep 23 | REPL Replimune | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.3 | 5,358 | 17.68 k | 86,333 |
22 Aug 23 | REPL Replimune | Common Stock | Sell | Dispose S | No | Yes | 20.01 | 18,600 | 372.19 k | 263,436 |
22 Aug 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 15.5 | 5,000 | 77.50 k | 282,036 |
22 Aug 23 | REPL Replimune | Common Stock | Option exercise | Acquire M | No | No | 3.3 | 13,600 | 44.88 k | 277,036 |